Home > Income Statement > IPCA LABORATORIES

IPCA LABORATORIES
Revenue

    Back to Income Statement
IPCA LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for IPCA LABORATORIES
Please provide your vote to see the results

IPCA LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹8,897 Cr₹7,662 Cr₹6,204 Cr₹5,797 Cr₹5,395 Cr

What is the latest Revenue of IPCA LABORATORIES ?

The latest Revenue ratio of IPCA LABORATORIES is ₹8,897 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹8,897 Cr
Mar2025₹7,662 Cr
Mar2024₹6,204 Cr
Mar2023₹5,797 Cr
Mar2022₹5,395 Cr

How is Revenue of IPCA LABORATORIES Trending?

Years Revenue % Change
Mar2026 ₹8,897 Cr
16.11
Mar2025 ₹7,662 Cr
23.50
Mar2024 ₹6,204 Cr
7.03
Mar2023 ₹5,797 Cr
7.45
Mar2022 ₹5,395 Cr -

Compare Revenue of peers of IPCA LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
IPCA LABORATORIES ₹49,723.9 Cr -0.3% 0.7% 48.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹457,073.0 Cr 8.1% 9.3% 9% Stock Analytics
DIVIS LABORATORIES ₹307,147.0 Cr 10.5% 18% 51.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,626.0 Cr 2.9% 2.1% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹115,685.0 Cr -0.1% 16% 14.6% Stock Analytics
CIPLA ₹113,589.0 Cr 1.4% 8.1% -6.8% Stock Analytics


IPCA LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
IPCA LABORATORIES

-0.3%

0.7%

48.3%

SENSEX

5.5%

13.3%

-3.4%


You may also like the below Video Courses